Sangamo Therapeutics, Inc. (SGMO) Q2 2025 Earnings Call Transcript

2025-08-08 14:53:54 ET

Sangamo Therapeutics, Inc. (SGMO)

Q2 2025 Earnings Conference Call

August 07 2025, 04:30 PM ET

Company Participants

Alexander D. Macrae - CEO, President & Director

Gregory Davis - Head of Research & Technology

Louise Wilkie - Head of Global Corporate Communications & Investor Relations

Nathalie Dubois-Stringfellow - Senior VP & Chief Development Officer

Prathyusha Duraibabu - Senior VP, CFO & Principal Accounting Officer

Conference Call Participants

James D Stamos - Jefferies LLC, Research Division

Joshua Seth Fleishman - TD Cowen, Research Division

Kuan-Hung Lin - Unidentified Company

Liu Deng - Barclays Bank PLC, Research Division

Luis Santos - Unidentified Company

Presentation

Operator

Good afternoon, and welcome to the Sangamo Therapeutics Second Quarter 2025 Teleconference Call. Please be advised that today's conference is being recorded....

Read the full article on Seeking Alpha

For further details see: